Medicinal Cannabis Users Drive More Cautiously After THC, but Can't Judge Their Own Impairment
Medicinal cannabis users showed no decline in hazard perception after oral THC, but drove more cautiously and could not accurately self-assess their performance.
Quick Facts
What This Study Found
Among 41 medicinal cannabis users, oral THC did not significantly impair hazard perception skill, but participants chose slower speeds and longer following distances after consumption. Critically, they could not accurately self-assess their performance regardless of whether they had consumed THC.
Key Numbers
N=41 medicinal cannabis users. No significant decline in hazard perception post-THC. Significantly slower speeds and longer following distances chosen. No correlation between perceived and actual performance.
How They Did This
Within-subjects study comparing 41 medicinal cannabis users on validated video-based driving measures at baseline (no THC) and after consuming oral THC oil.
Why This Research Matters
Medicinal cannabis patients need practical guidance about driving. This study suggests frequent users may compensate through cautious driving, but their inability to self-assess impairment remains a safety concern.
The Bigger Picture
Drug driving policy often treats all cannabis use equally, but this study suggests medicinal users who consume oral THC may behave differently than recreational users. The compensatory driving strategies are notable, as is the universal self-assessment failure.
What This Study Doesn't Tell Us
Video-based measures, not actual driving. Moderate sample size. Participants knew they were being tested, which may have prompted extra caution. Tolerance effects from regular use likely played a role.
Questions This Raises
- ?Do these compensatory strategies hold up in real-world driving?
- ?Should drug driving laws differentiate between medicinal and recreational cannabis users?
- ?Can any tool help patients assess their own driving fitness?
Trust & Context
- Key Stat:
- No hazard perception decline, but self-assessment of impairment was unreliable
- Evidence Grade:
- Within-subjects design with validated measures provides good internal validity, but moderate sample and video-based (not real driving) assessment limit conclusions.
- Study Age:
- 2025 study of current medicinal cannabis users in clinical settings.
- Original Title:
- The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.
- Published In:
- Psychopharmacology (2025)
- Database ID:
- RTHC-07135
Evidence Hierarchy
Watches what happens naturally without intervening.
What do these levels mean? →Frequently Asked Questions
Can medicinal cannabis patients drive safely after taking THC?
In this study, medicinal users showed no decline in hazard perception and actually drove more cautiously after oral THC. However, they could not accurately judge their own impairment, which remains a safety concern.
Do regular cannabis users develop tolerance to driving impairment?
This study of frequent medicinal users suggests some tolerance to hazard perception impairment, plus compensatory behaviors like driving slower. However, the inability to self-assess impairment persisted regardless of tolerance.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-07135APA
Mieran, Taren; Hill, Andrew; Horswill, Mark S; Summers, Mathew J; Stefanidis, Kayla B. (2025). The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.. Psychopharmacology. https://doi.org/10.1007/s00213-025-06869-w
MLA
Mieran, Taren, et al. "The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.." Psychopharmacology, 2025. https://doi.org/10.1007/s00213-025-06869-w
RethinkTHC
RethinkTHC Research Database. "The effects of orally ingested Delta-9-Tetrahydrocannabinol ..." RTHC-07135. Retrieved from https://rethinkthc.com/research/mieran-2025-the-effects-of-orally
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.